The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - EUSA Pharma
Research Funding - Ophelia Pharma
Travel, Accommodations, Expenses - EUSA Pharma; Jazz Pharmaceuticals
 
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer

Randomized use of anti-GD2 antibody dinutuximab beta (DB) long-term infusion with and without subcutaneous interleukin-2 (scIL-2) in high-risk neuroblastoma patients with relapsed and refractory disease: Results from the SIOPEN LTI-trial.
 
Holger N. Lode
Honoraria - Apeiron Biologics; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; EUSA Pharma
Research Funding - Apeiron Biologics
Patents, Royalties, Other Intellectual Property - CellAct Pharma
Travel, Accommodations, Expenses - EUSA Pharma
 
Dominique Valteau-Couanet
No Relationships to Disclose
 
Juliet Gray
Consulting or Advisory Role - EUSA Pharma
 
Roberto Luksch
No Relationships to Disclose
 
Aleksandra Wieczorek
No Relationships to Disclose
 
Victoria Castel
No Relationships to Disclose
 
Shifra Ash
No Relationships to Disclose
 
Genevieve Laureys
No Relationships to Disclose
 
Vassilios Papadakis
Travel, Accommodations, Expenses - Astellas Oncology; EUSA Pharma; Pfizer; Sanofi
 
Cormac Owens
No Relationships to Disclose
 
Alberto Garaventa
Travel, Accommodations, Expenses - Takeda
 
Carla Manzitti
No Relationships to Disclose
 
Nikolai Siebert
No Relationships to Disclose
 
Sascha Troschke-Meurer
No Relationships to Disclose
 
Evgenia Glogova
No Relationships to Disclose
 
Ulrike Poetschger
No Relationships to Disclose
 
Ruth Lydia Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics; EUSA Pharma
Travel, Accommodations, Expenses - Apeiron Biologics; EUSA Pharma